10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001683168-20-002645`
Period End Date	20200630
Filing Date	20200812
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	xbio-20200630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 54 Income Statement 52 Cash Flow Statement 48 Stockholders Equity 35

Balance Sheet 54 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	12.50M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	12.50M	shares	Point-in-time
Cash	`Cash`	$8.07M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	6.32M	shares	Point-in-time
Cash	`Cash`	$10.37M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	6.09M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$1.05M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	6.07M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$722.08K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	6.30M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$11.09M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.12M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$757.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$704.43K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.21M	USD	Point-in-time
Total assets	`Assets`	$21.55M	USD	Point-in-time
Total assets	`Assets`	$19.06M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$250.07K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$931.13K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$484.03K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$537.25K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.42M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$787.33K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.33M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.71M	USD	Point-in-time
Commitments (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 12,500,000 shares authorized as of June 30, 2020 and December 31, 2019; 6,323,218 and 6,092,432 shares issued as of June 30, 2020 and December 31, 2019, respectively; 6,296,227 and 6,065,441 shares outstanding as of June 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$6.32K	USD	Point-in-time
Common stock, $0.001 par value; 12,500,000 shares authorized as of June 30, 2020 and December 31, 2019; 6,323,218 and 6,092,432 shares issued as of June 30, 2020 and December 31, 2019, respectively; 6,296,227 and 6,065,441 shares outstanding as of June 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$6.09K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$188.24M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$188.52M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-166.01M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-168.14M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.39M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$17.21M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.91M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.52M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.36M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$16.20M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$21.55M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$19.06M	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`Revenues`	$169.68K	USD	2 Qtrs
Total revenues	`Revenues`	-	USD	1 Quarter
Total revenues	`Revenues`	-	USD	2 Qtrs
Total revenues	`Revenues`	$112.93K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$487.52K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$951.30K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$667.55K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$307.90K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.75M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$890.78K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.72M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$787.49K	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$1.38M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$2.71M	USD	2 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$2.38M	USD	2 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$1.10M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.71M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.38M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-982.46K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.21M	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$490.00	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$735.00	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$58.00	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$192.00	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$163.00	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$28.62K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$313.00	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$80.11K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$80.17K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$28.82K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$803.00	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$898.00	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.38M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.13M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-953.64K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.70M	USD	2 Qtrs
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	-	USD	1 Quarter
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	$3.88M	USD	2 Qtrs
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	-	USD	2 Qtrs
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	-	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.38M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-953.64K	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.58M	USD	2 Qtrs
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.13M	USD	2 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.15	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-7.79	USD	2 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-1.56	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.34	USD	2 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	844,749.00	shares	2 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.29M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.26M	shares	2 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	882,107.00	shares	1 Quarter

Cash Flow Statement 48 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.38M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.13M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-953.64K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.70M	USD	2 Qtrs
Depreciation	`Depreciation`	$757.00	USD	2 Qtrs
Depreciation	`Depreciation`	$1.00K	USD	1 Quarter
Depreciation	`Depreciation`	$200.00	USD	1 Quarter
Depreciation	`Depreciation`	$2.41K	USD	2 Qtrs
Amortization of right of use asset	`OtherDepreciationAndAmortization`	$10.18K	USD	2 Qtrs
Amortization of right of use asset	`OtherDepreciationAndAmortization`	$13.77K	USD	2 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$2.00K	USD	2 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	2 Qtrs
Gain on settlement with vendor	`GainsLossesOnExtinguishmentOfDebt`	$143.64K	USD	2 Qtrs
Gain on settlement with vendor	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Share-based expense	`ShareBasedCompensation`	$450.67K	USD	2 Qtrs
Share-based expense	`ShareBasedCompensation`	$277.33K	USD	2 Qtrs
Vendor share-based payments	`VendorShareBasedPayments`	$32.43K	USD	2 Qtrs
Vendor share-based payments	`VendorShareBasedPayments`	-	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-167.59K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$775.26K	USD	2 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$680.77K	USD	2 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-484.19K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.30M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.31M	USD	2 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	2 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$2.00K	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.00K	USD	2 Qtrs
Net proceeds from issuance of common stock and warrants	`ProceedsFromIssuanceOrSaleOfEquity`	$2.70M	USD	2 Qtrs
Net proceeds from issuance of common stock and warrants	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.70M	USD	2 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-2.30M	USD	2 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$396.10K	USD	2 Qtrs
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.03M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.07M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.37M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$638.12K	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.03M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.07M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.37M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$638.12K	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$8.00	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	-	USD	2 Qtrs
Right of use assets obtained in exchange for lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs
Right of use assets obtained in exchange for lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$43.33K	USD	2 Qtrs
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	-	USD	2 Qtrs
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$229.00	USD	2 Qtrs

Stockholders Equity 35 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$10.39M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$17.21M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$9.91M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$11.52M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$15.36M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$16.20M	USD	Point-in-time
Issuance of common stock and warrants in registered direct offering, net of issuance costs, value	`IssuanceOfCommonStockAndWarrantsInMarch2019RegisteredDirectOfferingNetOfIssuanceCostsValue`	$2.70M	USD	2 Qtrs
Exercise of pre-funded warrants, value	`ExerciseOfPrefundedWarrantsValue`	$509.00	USD	1 Quarter
Exercise of pre-funded warrants, value	`ExerciseOfPrefundedWarrantsValue`	$509.00	USD	2 Qtrs
Issuance of common stock to vendor, value	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	2 Qtrs
Issuance of common stock to vendor, value	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	1 Quarter
Issuance of common stock to vendor, value	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	2 Qtrs
Issuance of common stock to vendor, value	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	1 Quarter
Issuance of common stock to adjust for reverse split rounding, value	`StockIssuedDuringPeriodValueOther`	-	USD	2 Qtrs
Issuance of common stock to adjust for reverse split rounding, value	`StockIssuedDuringPeriodValueOther`	-	USD	1 Quarter
Deemed dividend related to Series B Preferred Stock down round provision	`DeemedDividendRelatedToSeriesBPreferredStockDownRoundProvision`	$3.88M	USD	2 Qtrs
Accretion of deemed dividend related to Series B Preferred Stock down round provision	`OtherPreferredStockDividendsAndAdjustments`	$3.88M	USD	2 Qtrs
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$277.33K	USD	2 Qtrs
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$111.73K	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$450.67K	USD	2 Qtrs
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$234.15K	USD	1 Quarter
Exercise of purchase warrants, value	`ExerciseOfPurchaseWarrantsValue`	-	USD	2 Qtrs
Exercise of purchase warrants, value	`ExerciseOfPurchaseWarrantsValue`	-	USD	1 Quarter
Common stock awards to vendors	`AdjustmentsToAdditionalPaidInCapitalOther`	$15.00K	USD	1 Quarter
Common stock awards to vendors	`AdjustmentsToAdditionalPaidInCapitalOther`	$32.43K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.38M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.13M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-953.64K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.70M	USD	2 Qtrs
Ending balance, value	`StockholdersEquity`	$10.39M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$17.21M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$9.91M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$11.52M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$15.36M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$16.20M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.